European Journal of Pediatrics

, Volume 162, Issue 10, pp 669–673

Chronic infantile neurological cutaneous articular syndrome: CD10 over-expression in neutrophils is a possible key to the pathogenesis of the disease

  • Valentina Leone
  • Gianni Presani
  • Sandra Perticarari
  • Alberto Tommasini
  • Sergio Crovella
  • Alessandro Lenhardt
  • Paolo Picco
  • Loredana Lepore
Original Paper


Chronic, Infantile, Neurological, Cutaneous and Articular Syndrome (CINCA) or Neonatal/Infantile Onset Multisystem Inflammatory Disease (NOMID/IOMID) is a rare, multisystem inflammatory disease characterised by neonatal onset of urticarial symptoms, persistent rash, ocular inflammatory lesions, progressive articular and neurological involvement and associated with characteristic overgrowth of the ossification nucleus of the patella. The tissues involved are extensively infiltrated by inflammatory cells, mostly neutrophils. This paper describes the clinical features of three new cases as well as a study of activation markers in neutrophils and search for mutations of the CIAS1gene in these patients. Clinical records of three cases of CINCA are reported. For genetic analysis, exon 3 of the CIAS1gene was amplified and sequenced. Immunophenotype, oxidative burst and phagocytosis were analysed in neutrophils obtained from all the three CINCA patients as well as from eight juvenile idiopathic arthritis (JIA) patients and eight healthy controls. Functional assays in neutrophils were normal in all three patients with CINCA syndrome and did not differ from those of JIA patients and healthy controls. The surface density of CD10 was significantly higher on neutrophils from CINCA patients as compared to those of JIA and controls ( P <0.0005). In one subject a new missense mutation in the CIAS1gene was identified. Conclusion: the hyper expression of the activation antigen CD10/NEP in neutrophils from these three cases of CINCA, as compared to JIA patients and healthy controls, irrespective of the presence of mutations in CIAS1, could be a marker of the inflammatory disorder typical of some patients with CINCA syndrome.


Chronic, infantile, neurological, cutaneous and articular syndrome (CINCA) Neonatal onset multisystem inflammatory disease (NOMID) CD10/neutral endopeptidase Neutrophil activation markers 



antinuclear antibodies


chronic, infantile, neurological, cutaneous and articular


juvenile idiopathic arthritis


mean fluorescence intensity


polymorphonuclear cell


  1. 1.
    Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, Stein L, Russo R, Goldsmith D, Dent P, Rosenberg HF, Austin F, Remmers EF, Balow JE Jr, Rosenzweig S, Komarow H, Shoham NG, Wood G, Jones J, Mangra N, Carrero H, Adams BS, Moore TL, Schikler K, Hoffman H, Lovell DJ, Lipnick R, Barron K, O'Shea JJ, Kastner DL, Goldbach-Mansky R (2002) De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin- associated autoinflammatory diseases. Arthritis Rheum 46: 3340–3348CrossRefPubMedGoogle Scholar
  2. 2.
    De Cunto CL, Liberatore DI, San Roman JL, Goldberg JC, Morandi AA, Feldman G (1997) Infantile-onset multisystem inflammatory disease: a differential diagnosis of systemic juvenile rheumatoid arthritis. J Pediatr 130: 551–556PubMedGoogle Scholar
  3. 3.
    Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T (2001) Neutrophil activation in Behcet's disease. Clin Exp Rheumatol 19: S19–S24PubMedGoogle Scholar
  4. 4.
    Feldmann J, Prieur AM, Quartier P, Berquin P, Cortis E, Teillac-Hamel D, Fischer A (2002) Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 71: 198–203CrossRefPubMedGoogle Scholar
  5. 5.
    Hashkes PJ, Lovell DJ (1997) Recognition of infantile-onset multisystem inflammatory disease as a unique entity. J Pediatr 130: 513–515PubMedGoogle Scholar
  6. 6.
    Hassink SG, Goldsmith DP (1983) Neonatal onset multisystem inflammatory disease. Arthritis Rheum 26: 668–673PubMedGoogle Scholar
  7. 7.
    Huttenlocher A, Frieden IJ, Emery H (1995) Neonatal onset multisystem inflammatory disease. J Rheumatol 22: 1171–1173PubMedGoogle Scholar
  8. 8.
    Kaufman RA, Lovell DJ (1986) Infantile-onset multisystem inflammatory disease: radiologic findings. Radiology 160: 741–746PubMedGoogle Scholar
  9. 9.
    Lachaux A, Hermier M, Foasso MF, Descos B, Collet JP, David L (1987) Severe, refractory neonatal inflammatory syndrome as the manifestation of a systemic multivisceral and meningeal syndrome. Arch Fr Pediatr 44: 125–128PubMedGoogle Scholar
  10. 10.
    Lampert F (1986) Infantile multisystem inflammatory disease: another case of a new syndrome. Eur J Pediatr 144: 593–596PubMedGoogle Scholar
  11. 11.
    Manji GA, Wang L, Geddes BJ, Brown M, Merriam S, Al Garawi A, Mak S, Lora JM, Briskin M, Jurman M, Cao J, Di Stefano PS, Bertin J (2002) PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B. J Biol Chem 277: 11570–11575CrossRefPubMedGoogle Scholar
  12. 12.
    Perticarari S, Presani G, Banfi E (1994) A new flow cytometric assay for the evaluation of phagocytosis and the oxidative burst in whole blood. J Immunol Methods 170: 117–124CrossRefPubMedGoogle Scholar
  13. 13.
    Prieur AM (2001) A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol 19: 103–106PubMedGoogle Scholar
  14. 14.
    Prieur AM, Griscelli C (1981) Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation. J Pediatr 99: 79–83PubMedGoogle Scholar
  15. 15.
    Prieur AM, Griscelli C, Lampert F, Truckenbrodt H, Guggenheim MA, Lovell DJ, Pelkonnen P, Chevrant-Breton J, Ansell BM (1987) A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol Suppl 66: 57–68PubMedGoogle Scholar
  16. 16.
    Richards N, Schaner P, Diaz A, Stuckey J, Shelden E, Wadhwa A, Gumucio DL (2001) Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem 276: 39320–39329CrossRefPubMedGoogle Scholar
  17. 17.
    Ruchon AF, Marcinkiewicz M, Ellefsen K, Basak A, Aubin J, Crine P, Boileau G (2000) Cellular localization of neprilysin in mouse bone tissue and putative role in hydrolysis of osteogenic peptides. J Bone Miner Res 15: 1266–1274PubMedGoogle Scholar
  18. 18.
    Stehlik C, Fiorentino L, Dorfleutner A, Bruey JM, Ariza EM, Sagara J, Reed JC (2002) The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappa B activation pathways. J Exp Med 196: 1605–1615CrossRefPubMedGoogle Scholar
  19. 19.
    Yarom A, Rennebohm RM, Levinson JE (1985) Infantile multisystem inflammatory disease: a specific syndrome? J Pediatr 106: 390–396PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Valentina Leone
    • 1
  • Gianni Presani
    • 2
  • Sandra Perticarari
    • 2
  • Alberto Tommasini
    • 1
  • Sergio Crovella
    • 3
  • Alessandro Lenhardt
    • 1
  • Paolo Picco
    • 4
  • Loredana Lepore
    • 1
  1. 1.Clinica PediatricaIRCCS Burlo GarofoloTriesteItaly
  2. 2.Laboratorio di ImmunologiaIRCCS Burlo GarofoloTrieste Italy
  3. 3.Dipartimento di Scienze della Riproduzione e dello Sviluppo, Unità di GeneticaUniversità di TriesteTriesteItaly
  4. 4.Seconda Divisione di PediatriaIRCCS G. GasliniGenova Italy

Personalised recommendations